Wednesday, July 6, 2022
Home Industry Pharma & Life Science

Pharma & Life Science

Why Must Enterprise Data Management Be a Strategic Capability for Life Sciences?

The global life sciences industry, which includes pharmaceuticals, biotechnology, and medical devices, has been on the rise, growing more rapidly than ever over the...

Pharmaceutical Translation: A Prescription for Improved Safety

The pharmaceutical industry has been working in partnership with international regulatory authorities and medical societies since the 1960s to develop standards that promote safety...

How Digitization and Automation is Meeting the Pharmaceutical Industry’s Need for Greater Manufacturing Capacity

In the pharmaceutical manufacturing industry, both the drug manufacturing process and the plant production environment are highly regulated to ensure product quality and safety. Constant...

Styrenics Market Global Top Industry Players Analysis and Development Trends by 2027, Revenue $134.9 Billion

Rising demand in the application of wind energy, surge in application in the automobile industry, and growth in demand for various plastic in consumer...

Some travelers are doubling up on the COVID-19 vaccine in the United States as the Delta virus spreads.

The United States Food and Drug Administration (FDA) approved a third vaccine dose for immunocompromised persons last week. Officials from the Department of Health...

Cannabidiol and Diabetes: Using CBD Oil to Rebalance Blood Sugar

  Description: CBD can treat several severe health conditions, which is why it is legal in some countries and can be purchased in the pharmacy....

FAB CBD Celebrates the Fourth While Continuing to Support Student

FAB CBD is well-known throughout the CBD industry and among avid CBD users as having top-quality, organic, clean CBD oil products. Moreover, the brand...

MEI Pharma to Host Investor and Analyst Video Webcast

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that it will host an investor and analyst...

Continuation of Partial Clinical Hold of Gemcabene From NeuroBo

NeuroBo Pharmaceuticals, Inc. a clinical-stage biotechnology company focused on developing and commercializing multimodal, disease-modifying therapies for neurodegenerative and cardiometabolic diseases, today announced that...

Modernizing Pharmaceutical R&D

Apart from continually reassessing strategic directions and moving with deliberate speed, pharma players are increasingly seeking to innovate their R&D services to stay ahead...

Must Read